Research in Chronic Viral Hepatitis: Archives of Virology. Supplementa, cartea 8
Editat de W.H. Gerlichen Limba Engleză Paperback – 21 dec 1993
Din seria Archives of Virology. Supplementa
- Preț: 404.29 lei
- Preț: 428.56 lei
- Preț: 391.40 lei
- 5% Preț: 381.54 lei
- 5% Preț: 1102.31 lei
- 5% Preț: 1313.93 lei
- 18% Preț: 961.55 lei
- 24% Preț: 820.00 lei
- Preț: 393.52 lei
- 5% Preț: 1014.10 lei
- 15% Preț: 600.26 lei
- 18% Preț: 1234.94 lei
- Preț: 397.76 lei
- 5% Preț: 384.80 lei
- Preț: 414.30 lei
- Preț: 399.29 lei
- Preț: 401.24 lei
- Preț: 424.33 lei
Preț: 401.03 lei
Nou
Puncte Express: 602
Preț estimativ în valută:
76.76€ • 79.10$ • 64.80£
76.76€ • 79.10$ • 64.80£
Carte tipărită la comandă
Livrare economică 01-15 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783211824979
ISBN-10: 3211824979
Pagini: 320
Ilustrații: XI, 304 p. 47 illus.
Dimensiuni: 210 x 279 x 17 mm
Greutate: 0.72 kg
Editura: SPRINGER VIENNA
Colecția Springer
Seria Archives of Virology. Supplementa
Locul publicării:Vienna, Austria
ISBN-10: 3211824979
Pagini: 320
Ilustrații: XI, 304 p. 47 illus.
Dimensiuni: 210 x 279 x 17 mm
Greutate: 0.72 kg
Editura: SPRINGER VIENNA
Colecția Springer
Seria Archives of Virology. Supplementa
Locul publicării:Vienna, Austria
Public țintă
ResearchCuprins
I. Replication of hepatitis viruses.- In vitro culture systems for hepatitis B and delta viruses.- Chronic infection in wood-chucks infected by a cloned hepatitis delta virus.- Detection of replicative intermediates of viral RNA in peripheral blood mononuclear cells from chronic hepatitis C virus carriers.- Susceptibility of human liver cell cultures to hepatitis C virus infection.- II. Molecular biology of hepatitis B virus.- Molecular basis of the diversity of hepatitis B virus core-gene products.- Characterization of the endogenous protein kinase activity of the hepatitis B virus.- The hepatitis B virus X gene product transactivates the HIV-LTR in vivo.- Accumulation of a cellular protein bearing c-myc-like antigenicity in hepatic and non-hepatic delta antigen expressing cells.- Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in ducks.- III. Pathogenic and protective immune responses against hepatitis viruses.- Cell mediated immune response to hepatitis B virus nucleocapsid antigen.- Clinical and immunological aspects of hepatitis B virus infection in children receiving multidrug cancer chemotherapy.- Hepatitis C virus infection in type II essential mixed cryoglobulinemias.- Detection of hepatitis B virus DNA by polymerase chain reaction in vaccinated and non-vaccinated Senegalese children.- Duck hepatitis B virus (DHBV) as a model for understanding hepadnavirus neutralization.- IV. Variability of hepatitis B virus.- Implication of genetic variation on the pathogenesis of hepatitis B virus infection.- Hepatitis B virus C-gene variants.- Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity.- Significance and relevance of serum preS1 antigen detection in wild-type and variant hepatitis B virus (HBV) infections.- Complete nucleotide sequences of six hepatitis B viral genomes encoding the surface antigen subtypes ayw4, adw4q?, and adrq? and their phylogenetic classification.- V. Diagnosis of chronic viral hepatitis.- Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations.- Serum IgM antibodies to hepatitis C virus in acute and chronic hepatitis C.- Isolate antibody to hepatitis C virus core antigen (C22) by RIB A 2: correlation with HCV-RNA and anti-NS5.- Is HCV transmitted by the vertical/perinatal route?.- VI. Clinical course and therapy of chronic viral hepatitis.- Multiple viral infections in HIV-infected children with chronically-evolving hepatitis.- Lymphoblastoid interferon in chronic hepatitis C patients that were “non responders” to recombinant interferon alpha (rIFN alpha).- Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus.- The relationship between LeY antigen and the therapeutic efficacy of interferon in chronic hepatitis C.- Antibodies to interferon alpha in patients.- VII. Liver transplantation and chronic viral hepatitis.- Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation.- Hepatitis C virus infection in liver allograft recipients.